The largest database of trusted experimental protocols

Agilent haloplex custom target enrichment

Manufactured by Agilent Technologies
Sourced in Canada

The Agilent Haloplex Custom Target Enrichment is a targeted enrichment solution for next-generation sequencing. It allows for the selective capture and sequencing of specific regions of the genome.

Automatically generated - may contain errors

2 protocols using agilent haloplex custom target enrichment

1

Targeted Sequencing for Rare Variants in AVSD

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genes enriched for rare (including novel) and rare/damaging non-synonymous variants in AVSD cases vs. EVS controls on mutation burden analysis were selected for targeted sequencing in the replication cohort using Agilent Haloplex Custom Target Enrichment (Agilent Technologies Inc., Santa Clara, CA). A custom probe set was designed using Agilent SureDesign web-based software to target all coding exons for the prioritized genes (earray.chem.agilent.com/suredesign). Sequencing (100 bp paired-end reads, targeted at >200X coverage) was performed using Illumina HiSeq2500 (Illumina Inc., San Diego, CA) at The Centre for Applied Genomics (TCAG) in The Hospital for Sick Children. Agilent SureCall software was used to generate BAM files and perform variant calling. Variants were annotated and filtered using the same protocol as for the primary cohort. To assess the population frequency of the recurring variant in MDM4 [8:204518457 A>C (K324Q, rs41299595)], genotyping was performed in 97 Caucasian controls without heart disease from Ontario using a custom-designed TaqMan® SNP Assays (Life Technologies Corporation) (Table S2.2). Samples were analyzed using the ViiA™ 7 Real-Time PCR System with ViiA™7 software.
+ Open protocol
+ Expand
2

Targeted Sequencing for Rare Variants in AVSD

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genes enriched for rare (including novel) and rare/damaging non-synonymous variants in AVSD cases vs. EVS controls on mutation burden analysis were selected for targeted sequencing in the replication cohort using Agilent Haloplex Custom Target Enrichment (Agilent Technologies Inc., Santa Clara, CA). A custom probe set was designed using Agilent SureDesign web-based software to target all coding exons for the prioritized genes (earray.chem.agilent.com/suredesign). Sequencing (100 bp paired-end reads, targeted at >200X coverage) was performed using Illumina HiSeq2500 (Illumina Inc., San Diego, CA) at The Centre for Applied Genomics (TCAG) in The Hospital for Sick Children. Agilent SureCall software was used to generate BAM files and perform variant calling. Variants were annotated and filtered using the same protocol as for the primary cohort. To assess the population frequency of the recurring variant in MDM4 [8:204518457 A>C (K324Q, rs41299595)], genotyping was performed in 97 Caucasian controls without heart disease from Ontario using a custom-designed TaqMan® SNP Assays (Life Technologies Corporation) (Table S2.2). Samples were analyzed using the ViiA™ 7 Real-Time PCR System with ViiA™7 software.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!